微信公众号
News Center
Industry News
2022-04-20
On April 2, 2022, the Planning, Development and Informatization Department of the National Health Commission issued the "Notice from the Office of the Healthy China Action Promotion Committee on Printing and Distributing the Key Work Points of Healthy China Action 2022".
Learn More Details
2022-03-29
JNCC Major Announcement! Academician He Jie’s Team Releases the Latest Cancer Data in China
Academician He Jie is the corresponding author of an article titled "Cancer Incidence and Mortality in China, 2016" published in JNCC. This study is based on the latest data from the National Cancer Center, selecting 487 high-quality monitoring sites from 682 cancer surveillance points nationwide, covering a population of 380 million, and provides a detailed account of the cancer disease burden in China in 2016.
Compared with 2015, the number of reporting monitoring sites increased by 181, and the number of high-quality monitoring sites increased by 119, indicating that the coverage of tumor registration work in our country is gradually advancing, and the data quality and standardization have further improved, providing stronger scientific evidence for the formulation of national health policies.
Learn More Details
2022-03-09
The Fifth Session of the 13th National People's Congress has opened. As a deputy to the National People's Congress, Yan Dapeng, Deputy Secretary of the Party Committee, Vice Chairman, and Chief Engineer of Raycus Laser, submitted a proposal to the congress this year regarding further support for the procurement of domestically produced equipment and instruments.
Learn More Details
2022-02-07
This ambitious new plan will help change the current cancer care and treatment methods and contribute to ending cancer.
Learn More Details
2022-01-12
National Health Commission: Promote early screening for tumors!
On October 15, the National Health Commission issued the "Notice on Printing and Distributing the Action Plan for Improving the Quality of Tumor Diagnosis and Treatment," further enhancing the quality level of tumor diagnosis and treatment, standardizing diagnostic and treatment behaviors, and ensuring medical quality and safety.
Learn More Details
2022-01-12
NMPA I "Regulations on Self-Inspection Management of Medical Device Registration" (2021 No. 126)
To strengthen the registration management of medical devices (including in vitro diagnostic reagents), standardize the self-inspection work of registration applicants, and ensure the orderly conduct of medical device registration review work, these regulations are formulated in accordance with the "Regulations on the Supervision and Administration of Medical Devices," "Measures for the Administration of Medical Device Registration and Filing," and "Measures for the Administration of In Vitro Diagnostic Reagent Registration and Filing."
Learn More Details